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Abstract
Background: To examine commonly used scoring systems, designed to predict overall outcome in critically ill
patients, for their ability to select patients with an abdominal sepsis that have ongoing infection needing
relaparotomy.
Methods: Data from a RCT comparing two surgical strategies was used. The study population consisted of 221
patients at risk for ongoing abdominal infection. The following scoring systems were evaluated with logistic
regression analysis for their ability to select patients requiring a relaparotomy: APACHE-II score, SAPS-II, Mannheim
Peritonitis Index (MPI), MODS, SOFA score, and the acute part of the APACHE-II score (APS).
Results: The proportion of patients requiring a relaparotomy was 32% (71/221). Only 2 scores had a discriminatory
ability in identifying patients with ongoing infection needing relaparotomy above chance: the APS on day 1 (AUC
0.61; 95%CI 0.52-0.69) and the SOFA score on day 2 (AUC 0.60; 95%CI 0.52-0.69). However, to correctly identify 90%
of all patients needing a relaparotomy would require such a low cut-off value that around 80% of all patients
identified by these scoring systems would have negative findings at relaparotomy.
Conclusions: None of the widely-used scoring systems to predict overall outcome in critically ill patients are of
clinical value for the identification of patients with ongoing infection needing relaparotomy. There is a need to
develop more specific tools to assist physicians in their daily monitoring and selection of these patients after the
initial emergency laparotomy.
Trial registration number: ISRCTN: ISRCTN 51729393
Background
Our group conducted a trial among patients with
abdominal sepsis comparing on-demand versus planned
relaparotomy after the initial emergency operation
(RELAP trial) [1]. We concluded that the on-demand
strategy should be preferred, based on comparable clini-
cal outcomes (12-month mortality 29% vs. 36%; P =
0.22), but a substantial reduction of healthcare utiliza-
tion and costs [1]. Planned relaparotomy yielded nega-
tive findings in 66% of patients and, thus, had no
therapeutic effect in these patients. Improvement of
patient selection for relaparotomy in the on-demand
strategy however is necessary as 31% of these patients
also had a negative relaparotomy [1].
The on-demand strategy implies a vigilant observation
of the postoperative peritonitis patient. Improvement of
outcome may follow improved monitoring following the
initial emergency (index) laparotomy and adequate
selection of patients with ongoing infection for reinter-
vention. Presently, the on-demand strategy includes reo-
peration when patients show clinical deterioration or do
not improve [1]. However, these conditions are not well
defined. There is no consensus or guideline on patient
monitoring to assist treating physicians in the selection
of patients for reoperation.
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the severity of disease in critically ill patients by predict-
ing mortality. As these prognostic scores are widely
incorporated in the daily treatment of ICU patients, we
questioned whether they would be useful in selecting
patients with ongoing abdominal infection needing a
relaparotomy or reintervention (by relaparotomy or by
percutaneous drainage).
Methods
Study population
The RELAP trial was a randomized controlled trial com-
paring relaparotomy on-demand with planned relaparot-
omy in patients with severe abdominal sepsis
(APACHE-II > 10) receiving an emergency laparotomy.
Details on inclusion criteria were reported in the article
presenting the main results [1]. The ‘on-demand’ strat-
egy was defined as performing a relaparotomy only in
case of clinical deterioration or lack of improvement,
monitored by physiological, laboratory and radiological
parameters. The planned strategy was defined as per-
forming a relaparotomy every 36 to 48 hours until the
abdomen was macroscopically clean at the beginning of
the final relaparotomy [1].
The trial cohort consisted of 229 patients of which 114
were randomly allocated to the on-demand strategy and
115 to the planned strategy. For the present study we
included patients from both arms, but excluded those
patients in whom the first relaparotomy took place more
than 7 days after the initial emergency operation (n = 8).
We maintained this 7-day period as ongoing infection
directly associated with the primary disease, is presumed
to occur within this time window. Moreover, the essential
difference between the planned and on-demand strategy
lies in the first relaparotomy being performed within two
or three days after index surgery in the planned strategy.
Commitment for relaparotomy on the second or third
day is not part of the on-demand strategy, but reconcilia-
tion of the need for relaparotomy is made day by day in
particular this first week.
Outcomes
Ongoing infection needing relaparotomy In the
planned strategy group ‘ongoing infection needing a
relaparotomy’ was defined as positive macroscopic find-
ings at relaparotomy. Moreover, all planned patients
who died within 14 days were classified as ‘ongoing
infection’. Death within this period was all cause. Within
this short time frame from emergency laparotomy mor-
tality was classified as due to (deterioration from)
underlying abdominal sepsis. A negative relaparotomy
(no residual infection or new pathology) was classified
as ‘no ongoing infection, not needing relaparotomy’.
In the on-demand treated patients only 48% received
a first relaparotomy. These patients were classified as
‘ongoing infection, needing a relaparotomy’ in case of
positive macroscopic findings at relaparotomy. In the
52% of on-demand patients not receiving relaparotomy
obviously no direct visual abdominal inspection was
performed. Therefore, we used a 14-day follow-up per-
iod as additional verification: a patient without visual
verification that died within this period was classified
as ‘ongoing infection needing relaparotomy’.P a t i e n t s
without visual verification who survived at least 2
weeks after index surgery were classified as ‘no
ongoing infection, not needing relaparotomy’ -a s s u m -
ing that if these patients would have received an early
relaparotomy, findings would have been negative (Fig-
ure 1).
Ongoing infection needing reintervention
Patients needing reintervention (n = 82) included all
patients that were classified as ‘ongoing infection need-
ing relaparotomy’ supplemented by patients that
received US- or CT-guided percutaneous drainage
(PCD) of abdominal fluid with placement of drains for
continuous drainage and lavage (n = 11; Figure 1).
Scoring systems
Widely-used scoring systems were evaluated for predict-
ing the need of relaparotomy after index operation.
Scoring systems evaluated were the Acute Physiology
and Chronic Health Evaluation (APACHE)-II score [2],
the simplified Acute Physiology Score (SAPS)-II [3], the
Mannheim Peritonitis Index (MPI) [4,5], the Multiple
Organ Dysfunction Score (MODS) [6], the Sepsis-related
Organ Failure Assessment (SOFA) score [7], and the
APS, the physiological part extracted from the
APACHE-II score [2].
The APACHE-II score was assessed, following the
RELAP trial protocol, using the worst values of each
independent constituent in a 24-hour time frame includ-
ing the index laparotomy [1]. The SAPS-II and MPI
were compiled by adding worst values of independent
constituents in the initial 24 hours following index
laparotomy.
Sequential scores, SOFA, APS and MODS were calcu-
lated on day 1 and 2, following index laparotomy by
adding worst values of independent constituents mea-
sured that day (Table 1).
Statistical analysis
Baseline characteristics Demographic data, clinical
characteristics and findings at index operation were
compared between patients who did or did not have
ongoing infection needing relaparotomy. Continuous
variables were expressed as mean ± standard deviation
or median (25-75% interquartile range) and compared,
respectively, using Student’s t-test or Mann-Whitney U-
test depending on the skewness of the data. Categorical
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with percentages) and analyzed using the c
2 test.
Predicting ‘ongoing infection needing relaparotomy’
To asses the ability of existing scoring systems to iden-
tify patients with ongoing infection needing relaparot-
omy we focused on the area under the receiver
operating characteristic (ROC) curve (AUC). AUC’sa r e
presented for the APACHE-II, SAPS-II and MPI at
index laparotomy. AUC’s are presented for the MODS,
SOFA score, and APS at day 1, day 2, and the absolute
difference between day 2 and day 1. Patients who were
already dead and patients who already received a rela-
parotomy prior to the day of the measurements were
not included in the analyses.
Logistic regression models were used to calculate
these AUC’s, also known as the concordance of c-statis-
tics. These logistic regression models also provide odds
ratios and 95% confidence intervals (CI) expressing the
strength of association between a risk score and the
probability of ongoing infection needing relaparotomy.
Although we tried to harmonize the definition of
ongoing infection needing relaparotomy across the two
Figure 1 Flow chart showing patient selection and outcome definition.
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there was a difference in predictive capability of one of
the existing scoring system between patients treated by
either surgical strategy. To examine this, logistic regres-
sion models were constructed containing type of surgi-
cal strategy, scoring system, and interaction between
surgical strategy and scoring system. A significant P-
value for the interaction term would indicate that the
predictive ability of such a scoring system was different
between surgical strategies, and probably related to a
difference in defining the outcome.
If a scoring system had a significantly better discrimi-
natory ability than can be expected by chance only
(AUC > 0.6), we calculated a specific cut-off point that
would have led to a sensitivity of 90%. Applying that
cut-off value would have identified 90% of all patients
needing relaparotomy and consequently miss 10% of
these patients. Such a cut-off analysis shows the conse-
quences of applying a specific cut-off value and in parti-
cular it reveals the number of patients not needing a
relaparotomy who would have been operated based
upon a score above the cut-off value (1-specificity).
Predicting ‘ongoing infection needing reintervention’
To assess the ability of existing scoring systems to iden-
tify patients with ongoing infection using the wider defi-
nition of ‘needing reintervention’, we determined the
AUC’s as measure of predictive value for ‘ongoing infec-
tion needing reintervention’ [8].
Predicting mortality
To verify consistency of data we examined the ability of
examined scoring systems to predict mortality, the very
purpose for which they were originally developed and
validated. We again used AUC’s to express the ability of
each score to discriminate between patients who died
in-hospital and those who survived their hospital admis-
sion [8].
Missing values
The various existing scoring systems were based on a
multitude of different variables that had to be recorded
prospectively per protocol on consecutive days upon
inclusion of the RELAP trial. There were inevitably
missing values in our dataset. Data checks were per-
formed to detect any available missing values.
Although we had a low rate of missing values, in a
compository score it would introduce uncertainty even
when values of other variables were present. Therefore,
we used multiple imputation to replace missing values
with a set of plausible values that represent the uncer-
tainty around the right value to impute. The multivari-
ate relationships between all underlying variables were
used to impute missing values (Markov Chain Monte
Carlo, SAS). Appropriate transformations were applied
to individual variables to improve normality [9,10]. For
patients not admitted to the ICU at day 1 and/or day 2
normal values were imputed for components specifically
associated with ICU care (central venous pressure, air
oxygen pressure (FiO2) in case of no oxygen suppletion,
arterial oxygenation (PaO2), and Glascow coma scale)
[11].
The multiple imputed data sets were analyzed (one by
one) using standard procedures (e.g. logistic regression)
for complete data. Then the results from these analyses
were combined to produce estimates and confidence
intervals that properly reflect the uncertainty due to
missing values. We used a total of ten rounds of
Table 1 Overview of components of the various existing
scoring systems.
APACHE-
II
SAPS-
II
MPI SOFA MODS APS
Type of admission √
Age √√ √
Gender √
Chronic disease present √√
Malignant comorbidity √
Organ failure present √
Temperature √√ √
White blood cell counts √√
Oxygenation
a √√ √ √ √
Mechanical ventilation √
Respiratory rate √√
Arterial pH √√
HCO3
- √
Cardiovascular state
b √
Heart rate √√ √ √
Blood pressure
c √√ √ √ √
Hematocrit √√
Creatinine √√ √ √
Urine output √√
Urea √
Bilirubin √√ √
Coagulation
(thrombocytes)
√√
Potassium √√ √
Sodium √√ √
Glasgow coma score √√ √ √
Disease specific
parameters
d
√
a PaO2 or PaO2/FiO2 ratio
b includes administration and dosage of (nor)epinephrine, dopamine or
dobutamine
c systolic blood pressure, mean arterial pressure (MAP) or as part of the
pressure adjusted heart rate (PAR)
d disease specific parameters include duration of peritonitis, origin, extent of
peritonitis and type of contamination.
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confidence intervals [9,10,12-14].
P-values less than 0.05 were considered statistically
significant. Statistical analyses were carried out using
SAS 9.1 (SAS Institute, Cary, NC, USA).
Results
Patient inclusion
The study population consisted of 221 patients at risk
for ongoing infection after emergency laparotomy
because of secondary peritonitis. Figure 1 shows that
using the specified outcome definition 71 patients (32%)
were classified as ‘ongoing infection needing
relaparotomy’.
For the sequential scoring systems, 3 patients were
excluded from the analyses at day 1, because 1 patient
had a relaparotomy within several hours of the index
laparotomy and 2 patients had died. For analyses at day
2s o m em o r ep a t i e n t sw e r ee x c l u d e df r o ma n a l y s e s :1 2
patients had already undergone a relaparotomy and 1
patient had died, leaving 205 patients available for ana-
lyses (needing relaparotomy n = 64).
Table 2 lists the demographic and baseline character-
istics of both outcome groups. More than 90% of
patients had been admitted to the ICU. As can be
expected, patients classified as ‘ongoing infection need-
ing relaparotomy’ had a significant longer ICU stay and
high mortality rate.
Predicting ‘ongoing infection needing relaparotomy’
None of the interactions between existing scoring sys-
tems and the applied surgical strategy (on-demand or
planned relaparotomy strategy) were significant with P-
values ranging from 0.098 to 0.982. Therefore, all ROC
analyses were based on the total cohort of patients from
the RELAP trial (Table 3). The ROC curves showing
pairs of sensitivity and specificity for possible cut-off
values are presented in Figure 2.
T h es i n g l et i m ep o i n ts e v e r i t yo fd i s e a s es c o r e s ,
APACHE-II score, SAPS-II and MPI showed no
predictive value for ‘ongoing infection needing relaparot-
omy’ with AUC’s all below 0.6 (Table 3, Figure 2).
The SOFA score had no predictive value on day 1
(AUC 0.57, 95%CI 0.49-0.65) but improved to modest
on day 2 (AUC 0.60, 95%CI 0.52-0.69; Table 3, Figure
2). The absolute difference (delta SOFA measurements
between day 2 and day 1) showed no discriminatory
value. The MODS also showed no discriminatory value
for ongoing infection on either consecutive day (Table
3, Figure 2).
The APS, however, showed a modest discriminatory
ability at day 1 with an AUC of 0.61 (95%CI 0.52-0.69),
at day 2 the AUC was 0.56 (95%CI 0.47-0.65; Table 3,
Figure 2).
90% sensitivity
For scoring systems that performed significantly better
than chance, we determined a cut-off score that would
produce a sensitivity of 90% and then calculated the
proportion of patients undergoing an unnecessary rela-
parotomy (1-specificity).
A score of 3.1 determined for the APS would have
identified 90% of the patients requiring a relaparotomy,
but the corresponding specificity was only 17%. Based
on this cut-off value, the positive predictive value would
have been 33%, indicating that for all 186 patients with
a score above this cut-off of 3.1 only 62 patients would
have been rightfully reoperated, and 124 patients would
have been reoperated under suspicion of ongoing
abdominal infection but with negative findings at rela-
parotomy. The negative predictive value, based on this
cut-off value, would have been 78%, indicating that 25
of the 32 patients with a score under the cut-off value
of 3.1 would rightfully not have been reoperated. How-
ever, 7 patients with ongoing infection needing relapar-
otomy would have been withheld from relaparotomy
(Table 4).
The 90% sensitivity cut-off for day 2 SOFA scores
(1.4) would have a positive predictive value of 32% and
a negative predictive value of 73% (Table 4).
Table 2 Demographic, initial peritonitis and recovery data for all 221 included patients.
Characteristic Ongoing infection needing relaparotomy
(n = 71)
No ongoing infection, not needing relaparotomy
(n = 150)
P-value
Median age (IQR) 69 (57 to 74) 70 (57 to 76) 0.36
Male n (%) 38 (54%) 65 (43%) 0.16
Postoperative peritonitis n (%) 32 (45%) 71 (47%) 0.75
Generalized peritonitis n (%) 47 (66%) 88 (59%) 0.48
ICU admission n (%) 69 (97%) 135 (90%) 0.061
Length of ICU stay 12 (7 to 32) 7 (4 to 16) 0.001
Length of index hospital stay 32 (17 to 74) 28 (17 to 49) 0.28
In-hospital mortality n (%) 26 (37%) 23 (15%) < 0.001
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Eighty-two patients were classified as ‘ongoing infection
needing reintervention’ (Figure 1). Only the APS at day
1s h o w e da nA U C0 . 6f o rp r e d i c t i o no f‘ongoing infec-
tion needing reintervention’ (95%CI 0.52-0.68; Table 5).
Predicting mortality
All evaluated scoring systems were predictive of mortal-
ity in peritonitis patients, as score AUC’sw e r es i g n i f i -
cantly different from an AUC of 0.5 (Table 5).
Discussion
The predictive value of available scoring systems, in par-
ticular those that can be assessed sequentially, for
ongoing abdominal infection needing relaparotomy is
not known. In clinical practice changes in organ func-
tions are seen as useful triggers to expand diagnostic
tools or intervention. However, only the SOFA score
and APS had equally modest discriminatory ability for
predicting ongoing infection needing relaparotomy.
Furthermore, they showed an extremely low specificity
for a 90% sensitivity. Broadening the definition of
ongoing abdominal infectionb yp a t i e n t sn e e d i n gr e i n -
tervention (relaparotomy or percutaneous drainage) did
not enhance identification of patients with persistent
peritonitis.
The RELAP trial concludes that the on-demand strat-
egy is preferred [1]. Stringent monitoring of patients is a
vital component of this strategy. A scoring system can
aid in adequate and timely identification of patients for
relaparotomy. Ideally, such a prediction model should
be a sequential score. Changes in organ failure may be
of better value in objectifying the clinical course of the
disease, in particular since postoperative (follow-up)
Table 3 Mean scores with associated standard deviations (SD) compared for patients with ‘ongoing infection needing
relaparotomy’ (n = 71) and patients with ‘no ongoing infection, not needing relaparotomy’ (n = 150).
Score Ongoing infection [Mean score (SD)] No ongoing infection, [Mean score (SD)] AUC (95% CI) P-value
a
APACHE-II 16.1 (4.8) 15.8 (4.0) 0.50 (0.42 to 0.58) 0.961
SAPS-II 40.2 (12.3) 36.0 (11.3) 0.59 (0.51 to 0.67) 0.033
MPI 26.8 (6.9) 26.5 (7.9) 0.51 (0.43 to 0.59) 0.824
SOFA (day 1)
b 7.3 (3.8) 6.4 (3.4) 0.57 (0.49 to 0.65) 0.108
SOFA (day 2)
c 6.8 (3.8) 5.8 (3.4) 0.60 (0.52 to 0.69) 0.017
SOFA Delta (day 2-1)
c -0.17 (2.2) -0.93 (2.3) 0.58 (0.50 to 0.66) 0.073
MODS (day 1)
b 5.0 (3.0) 4.3 (2.7) 0.56 (0.48 to 0.64) 0.141
MODS (day 2)
c 4.2 (3.0) 3.7 (2.6) 0.54 (0.45 to 0.63) 0.349
MODS Delta (day 2-1)
c -0.48 (1.8) -0.60 (1.8) 0.52 (0.43 to 0.60) 0.726
APS (day 1)
b 8.3 (4.6) 6.6 (3.6) 0.61 (0.52 to 0.69) 0.012
APS (day 2)
c 6.8 (3.7) 5.9 (3.2) 0.56 (0.47 to 0.65) 0.154
APS Delta (day 2-1)
c -1.03 (3.7) -0.64 (3.7) 0.55 (0.46 to 0.63) 0.277
a P-value wether different from an AUC of 0.50
b patients deceased on day 0 (n = 2) and patient receiving relaparotomy on day 0 (n = 1) excluded
c patients deceased on day 0 and 1 (n = 3) and patients receiving relaparotomy on day 0 and 1 (n = 13) excluded
Figure 2 Receiver operating characteristic (ROC) curves associated with the area under the curves depicted in Table 3.R O C ’sa r e
displayed for the scoring systems measured at a single time point (APACHE-II(), SAPS-II(), MPI() compared to the reference line ()) and for
sequential scoring systems (MODS(), SOFA(), APS() compared to the reference line ()) measured at day 1 and at day 2.
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available during index laparotomy [15].
We were surprised by the low performance of these
well-known scoring systems, as most of these scores
quantify organ function. However, none of the evaluated
scoring systems were originally developed to predict the
need of a relaparotomy for ongoing peritonitis following
emergency laparotomy in the acute phase of the disease
[2-7]. All scores, except the MPI, have been developed
to predict death for ICU patients in general and for
groups of patients (strata) rather than predicting death
for individual patients [2,3,6,7]. Although the MPI is
specifically developed for patients with abdominal sepsis,
it is focused on prediction of death rather than occur-
rence of ongoing infection [16]. Also, the MPI largely
consists of peritonitis-related data, determined at the
initial emergency laparotomy [5]. These variables are
described to be less predictive than physiological post-
operative variables [15]. All scores, indeed, did better at
predicting death, as they are developed and validated to
do.
Prognostic relevance of the SOFA score in combina-
tion with inflammatory parameters was also found in a
recent study conducted by Zügel et al., even though
Table 4 Performance of scoring systems, moderately predictive for ‘ongoing infection needing relaparotomy’ (AUC >
6.0; SOFA day 2 and APS day 1), in selecting patients for relaparotomy using a cut-off value based on a 90%
sensitivity.
Relaparotomy required
Yes No
SOFA Above 1.4 57 122 PPV
a = 32%
cut-off Below 1.4 7 19 NPV
b = 73%
(range score 0-18) Sensitivity = 90% Specificity = 13%
total 64 141
Yes No
APS Above 3.1 62 124 PPV
a = 33%
cut-off Below 3.1 7 25 NPV
b = 78%
(range score 0-56) Sensitivity = 89% Specificity = 17%
total 69 149
a positive predictive value
b negative predictive value
Table 5 Predictive value comparing patients needing a reintervention (n = 82) with not needing reintervention and
for inhospital mortality (n = 49).
Score AUC (95% CI) P-value whether AUC different from 0.5
Reintervention (n = 82)
APACHE-II 0.49 (0.41 to 0.57) 0.860
SAPS-II 0.56 (0.48 to 0.64) 0.145
MPI 0.52 (0.44 to 0.60) 0.666
SOFA (day 1)
a 0.55 (0.47 to 0.63) 0.205
SOFA (day 2)
b 0.57 (0.49 to 0.65) 0.088
MODS (day 1)
a 0.55 (0.47 to 0.63) 0.199
MODS (day 2)
b 0.53 (0.45 to 0.61) 0.469
APS (day 1)a 0.60 (0.52 to 0.68) 0.019
APS (day 2)
b 0.53 (0.44 to 0.61) 0.531
Inhospital mortality (n = 49)
APACHE-II 0.74 (0.65 to 0.82) < 0.001
SAPS-II 0.80 (0.73 to 0.87) < 0.001
MPI score 0.60 (0.52 to 0.69) 0.026
SOFA (day 1)
c 0.72 (0.63 to 0.81) < 0.001
MODS (day 1)
c 0.76 (0.68 to 0.83) < 0.001
APS (day 1)
c 0.68 (0.59 to 0.77) < 0.001
a patients deceased on day 0 (n = 2) and patient receiving relaparotomy on day 0 (n = 1) excluded
b patients deceased on day 0 and 1 (n = 3) and patients receiving relaparotomy on day 0 and 1 (n = 13) excluded
c patients deceased on day 0 (n = 2) and patient receiving relaparotomy on day 0 (n = 1) excluded
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[17]. Torer et al. and Tan et al. identified possible prog-
nostic relevance for the MPI in retrospective cohorts
with patients with secondary peritonitis due to post-
operative complications and community acquired per-
forations of small bowel and colon [17-20]. However,
quantification of or changes in organ failure does not
seem to differentiate between ongoing organ failure due
to abdominal sepsis despite source control of the initial
causative focus and ongoing abdominal infection.
For the non-reoperated patients, the time frame in
which the predictor status of the sequential scoring sys-
tems was assessed was less precise. Our best deduction
was to evaluate the scores during the clinical phase in
which the dilemma of early relaparotomy is most promi-
nent; day 1 and day 2 after the initial emergency lapar-
otomy, for all included patients. In view of the
disappointing predictive values, it is unlikely that exten-
sion of assessment after day 2 would have revealed com-
pletely different results.
Patients included in this study were randomized to the
on-demand or the planned strategy [1]. This enhances
the generalizability of the results but foremost eliminates
selection bias in choice of practiced treatment strategies.
Differences in these treatment arms did lead to differen-
tial verification, but not necessarily to verification bias.
Another option would have been to use only the
planned arm of the trial, as all these patients were reop-
erated and had uniform outcome verification. Instead,
all existing scoring systems were tested for the assump-
tion that both the on-demand and planned strategy
could be combined for the above analyses and we found
no significant interaction between treatment strategies
and predictive ability of the various scoring systems.
This means that the predictive ability of existing scoring
systems is comparable for both on-demand and planned
treated patients. Importantly, also the proportion of
events (positive findings at relaparotomy) was compar-
able for both strategies (29% for on-demand vs. 32% for
planned) [1].
For clinical purposes, discriminatory power is more
important than stratification. A 90% level of sensitivity
was employed, as it is considered worse to mistakenly
not re-operate a patient with ongoing infection needing
relaparotomy than it is to reoperate a patient on the
suspicion of ongoing infection but with negative findings
[15,21]. The approximate of 90% sensitivity was chosen
to determine a cut-off for adequate scoring systems,
reflecting the trade-off between a false positive predic-
tion of peritonitis (negative relaparotomy) and a false
negative prediction of peritonitis (no relaparotomy
although one is needed). Nevertheless, performing too
many negative relaparotomies should be avoided [22].
None of the scoring systems had a clinical important
predictive value nor demonstrated a clinically useful dis-
criminatory ability. In order not to withhold relaparot-
omy from too many patients who need treatment for
ongoing infection, an unacceptable high proportion of
inappropriate relaparotomies would be performed based
on the scores.
All presented, existing scoring systems lack the addi-
tional information derived from diagnostic imaging
techniques which is likely valuable for selection of
patients with ongoing infection needing reintervention.
For patients suspected of abdominal infection following
elective abdominal surgery, CT imaging has a high diag-
nostic accuracy [23]. The exact value of diagnostic ima-
ging in operated peritonitis patients with suspected
ongoing abdominal infection is not known, as conse-
quences from management decisions based on CT
results have not been evaluated yet. Future research is
needed to determine the exact accuracy of CT scanning
in on-demand treated peritonitis patients who are sus-
pected of ongoing infection.
Conclusions
None of the existing and widely used severity-of-disease
scores, specifically developed for critically ill patients,
was clinically useful in the identification of patients with
ongoing infection needing a relaparotomy. Therefore,
new tools need to be developed that specifically incor-
porate parameters indicative for ongoing abdominal
infection, rather than merely ongoing organ failure, in
patients with abdominal sepsis. Preferentially, these spe-
cific tools combine clinical findings, laboratory measure-
ments and results from diagnostic imaging tests to assist
the multidisciplinary team in selecting patients for rein-
tervention to treat ongoing abdominal infection.
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